Lion Point Capital

Lion Point Capital as of June 30, 2026

Portfolio Holdings for Lion Point Capital

Lion Point Capital holds 35 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cue Biopharma (CUE) 8.0 $1.7M 53k 31.56
Praxis Precision Medicines I Com New (PRAX) 7.1 $1.5M 4.5k 334.79
Moonlake Immunotherapeutics Class A Ord (MLTX) 6.3 $1.3M 68k 19.47
Fennec Pharmaceuticals (FENC) 5.8 $1.2M 112k 10.75
Royalty Pharma Shs Class A (RPRX) 5.7 $1.2M 21k 56.07
Compass Pathways Sponsored Ads (CMPS) 5.4 $1.1M 80k 14.15
Milestone Pharmaceuticals (MIST) 5.3 $1.1M 820k 1.34
Benitec Biopharma Com New (BNTC) 4.0 $830k 62k 13.38
Syndax Pharmaceuticals (SNDX) 3.8 $787k 36k 21.86
Biohaven (BHVN) 3.7 $769k 52k 14.88
Geron Corporation (GERN) 3.5 $740k 578k 1.28
Uniqure Nv SHS (QURE) 3.2 $677k 15k 46.06
Ardelyx (ARDX) 3.1 $656k 129k 5.10
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) 2.9 $610k 5.5k 110.94
Disc Medicine (IRON) 2.8 $592k 8.1k 73.14
Sarepta Therapeutics (SRPT) 2.4 $512k 29k 17.97
Humacyte (HUMA) 2.4 $507k 650k 0.78
Kura Oncology (KURA) 2.4 $505k 46k 10.97
Viatris (VTRS) 2.1 $440k 28k 15.88
Dyne Therapeutics (DYN) 1.9 $400k 18k 22.21
Bridgebio Pharma (BBIO) 1.8 $372k 5.0k 74.48
Edgewise Therapeutics (EWTX) 1.8 $370k 9.1k 40.63
Pacira Pharmaceuticals (PCRX) 1.6 $343k 14k 25.37
Regenxbio Inc equity us cm (RGNX) 1.5 $319k 27k 11.98
Rocket Pharmaceuticals (RCKT) 1.4 $294k 86k 3.42
Janux Therapeutics (JANX) 1.4 $292k 19k 15.36
Mineralys Therapeutics (MLYS) 1.4 $283k 11k 26.98
Gh Research Ordinary Shares (GHRS) 1.3 $274k 10k 26.88
Seres Therapeutics Com New (MCRB) 1.2 $249k 32k 7.89
Brooks Automation (AZTA) 1.2 $248k 9.7k 25.52
Jasper Therapeutics Com New (JSPR) 0.9 $196k 465k 0.42
Innoviva (INVA) 0.9 $186k 8.2k 22.71
Innate Pharma S A Sponsored Ads (IPHA) 0.7 $149k 81k 1.84
Arcutis Biotherapeutics (ARQT) 0.7 $138k 5.3k 26.22
Spruce Biosciences Com New (SPRB) 0.3 $54k 1.0k 54.00